![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/myeloid-therapeutics-presents-multiple-posters-at-the-american-society-of-gene--cell-therapy-asgct-2024-annual-meeting-302137520.html
https://www.prnewswire.com/news-releases/prime-medicine-and-myeloid-therapeutics-announce-settlement-of-pending-disputes-302027502.html
https://www.prnewswire.com/news-releases/myeloid-announces-appointment-of-matthew-maurer-md-as-chief-medical-officer-302007175.html
https://www.prnewswire.com/news-releases/myeloid-therapeutics-to-participate-at-svb-securities-biopharma-company-connect-event-301832159.html
https://www.contractpharma.com/contents/view_breaking-news/2023-05-19/myeloid-therapeutics-gets-73m-financing-for-mrna-based-immunotherapy-pipeline/?widget=listSection
https://endpts.com/exclusive-myeloid-therapeutics-raises-73m-bringing-in-arch-ahead-of-in-vivo-program-entering-the-clinic/
https://endpts.com/myeloid-therapeutics-goes-down-under-for-new-manufacturing-site-with-66m-local-investment/
https://www.prnewswire.com/news-releases/myeloid-therapeutics-to-present-at-the-guggenheim-healthcare-talks-2023-oncology-day-301735349.html
https://www.prnewswire.com/news-releases/myeloid-therapeutics-announces-fda-fast-track-designation-for-mt-101-for-the-treatment-of-cd5-relapsedrefractory-ptcl-301661208.html
https://www.prnewswire.com/news-releases/myeloid-therapeutics-enters-into-agreement-with-acuitas-therapeutics-for-lipid-nanoparticle-lnp-system-enabling-the-first-ever-delivery-of-mrna-encoded-cars-directly-to-humans-301551149.html